Answer
No. It is an MAO-B inhibitor that reduces dopamine breakdown rather than directly stimulating dopamine receptors.
Sources for this answer
- Rasagiline Brown and Burk 1mg Tablets — Current selected SmPCemc · Summary of Product Characteristics
- NHSNHS · NHS medicine guidance
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.